Skip to main content

Table 1 Median and range for average number of nocturia episodes, voided output, and NPI by treatment with treatment p-value and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure Treatment
Baseline A: Placebo B: Melatonin p d
Median Range Median Range Median Range
Average Nocturia Episodes 1.70 1–3 1.50 0–3 1.30 0–3.3 0.618 0.136
Average nocturnal urine output (mls) 741 310–1416 651 300–1933 667 200–1100 0.939 0.020
24-h voided volume (mls) 2125 1200–4000 2213 1250–3900 2000 881–3600 0.254 0.314
Nocturnal Polyuria Index NPI 0.32 0.15–0.71 0.33 0.17–0.56 0.32 0.15–0.60 0.849 0.052